-
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes AssociationCS Fox, SH Golden et al. -
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialde Winter RJ, Katagiri Y, Serruys PW et al.
-
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunctionTJ Ford, D Corcoran, S Padmanabhan et al.
-
The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary InterventionA Marques, I Cruz, I João et al.
-
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trialM Mancone, R Cavalcante, PW Serruys et al.
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesStone NJ, Robinson JG, American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
-
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularizationCrea F, Bairey Merz CN, Beltrame JF et al.
-
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusionsWerner GS, Martin-Yuste V, EUROCTO trial investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
